{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:28:57Z","timestamp":1791419337639,"version":"4.3.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T00:00:00Z","timestamp":1457913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1038\/nm.4062","type":"journal-article","created":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T15:34:03Z","timestamp":1457969643000},"page":"379-387","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["PTEN opposes negative selection and enables oncogenic transformation of pre-B cells"],"prefix":"10.1038","volume":"22","author":[{"given":"Seyedmehdi","family":"Shojaee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai N","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Buchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Cazzaniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadriye Nehir","family":"Cosgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Hua","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus D\u00fchren","family":"von Minden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hochhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Cazzaniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Melnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M","family":"Kornblau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G","family":"Graeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Jumaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"M\u00fcschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,14]]},"reference":[{"key":"BFnm4062_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0952-7915(91)90047-5","volume":"3","author":"DG Osmond","year":"1991","unstructured":"Osmond, D.G. Proliferation kinetics and the lifespan of B cells in central and peripheral lymphoid organs. Curr. Opin. Immunol. 3, 179\u2013185 (1991).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnm4062_CR2","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1126\/science.1086907","volume":"301","author":"H Wardemann","year":"2003","unstructured":"Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374\u20131377 (2003).","journal-title":"Science"},{"key":"BFnm4062_CR3","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1126\/science.1157533","volume":"321","author":"RA Keenan","year":"2008","unstructured":"Keenan, R.A. et al. Censoring of autoreactive B cell development by the pre-B cell receptor. Science 321, 696\u2013699 (2008).","journal-title":"Science"},{"key":"BFnm4062_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.cell.2009.08.041","volume":"139","author":"L Srinivasan","year":"2009","unstructured":"Srinivasan, L. et al. PI3 kinase signals BCR-dependent mature B cell survival. Cell 139, 573\u2013586 (2009).","journal-title":"Cell"},{"key":"BFnm4062_CR5","doi-asserted-by":"publisher","first-page":"ra60","DOI":"10.1126\/scisignal.2001104","volume":"3","author":"F Ramadani","year":"2010","unstructured":"Ramadani, F. et al. The PI3K isoforms p110-\u03b1 and p110-\u03b4 are essential for pre-B cell receptor signaling and B cell development. Sci. Signal. 3, ra60 (2010).","journal-title":"Sci. Signal."},{"key":"BFnm4062_CR6","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1172\/JCI75746","volume":"124","author":"MC Deau","year":"2014","unstructured":"Deau, M.C. et al. A human immunodeficiency caused by mutations in the PIK3R1 gene. J. Clin. Invest. 124, 3923\u20133928 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnm4062_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"I Vivanco","year":"2002","unstructured":"Vivanco, I. & Sawyers, C.L. The phosphatidylinositol 3-kinase\u2013AKT pathway in human cancer. Nat. Rev. Cancer 2, 489\u2013501 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm4062_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrc1299","volume":"4","author":"PA Futreal","year":"2004","unstructured":"Futreal, P.A. et al. A census of human cancer genes. Nat. Rev. Cancer 4, 177\u2013183 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm4062_CR9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1182\/blood-2009-02-206722","volume":"114","author":"A Gutierrez","year":"2009","unstructured":"Gutierrez, A. et al. High frequency of PTEN, PI3K and AKT abnormalities in T cell acute lymphoblastic leukemia. Blood 114, 647\u2013650 (2009).","journal-title":"Blood"},{"key":"BFnm4062_CR10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/gene.10036","volume":"32","author":"R Lesche","year":"2002","unstructured":"Lesche, R. et al. Cre-loxP\u2013mediated inactivation of the murine Pten tumor suppressor gene. Genesis 32, 148\u2013149 (2002).","journal-title":"Genesis"},{"key":"BFnm4062_CR11","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","volume":"118","author":"J Zhang","year":"2011","unstructured":"Zhang, J. et al. Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 118, 3080\u20133087 (2011).","journal-title":"Blood"},{"key":"BFnm4062_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S1074-7613(00)00024-8","volume":"13","author":"B Guo","year":"2000","unstructured":"Guo, B., Kato, R.M., Garcia-Lloret, M., Wahl, M.I. & Rawlings, D.J. Engagement of the human pre-B cell receptor generates a lipid raft\u2013dependent calcium signaling complex. Immunity 13, 243\u2013253 (2000).","journal-title":"Immunity"},{"key":"BFnm4062_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S1074-7613(00)00079-0","volume":"13","author":"T Okada","year":"2000","unstructured":"Okada, T., Maeda, A., Iwamatsu, A., Gotoh, K. & Kurosaki, T. BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity 13, 817\u2013827 (2000).","journal-title":"Immunity"},{"key":"BFnm4062_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/ni892","volume":"4","author":"AN Anzelon","year":"2003","unstructured":"Anzelon, A.N., Wu, H. & Rickert, R.C. Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat. Immunol. 4, 287\u2013294 (2003).","journal-title":"Nat. Immunol."},{"key":"BFnm4062_CR15","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1182\/blood-2007-08-109769","volume":"111","author":"Y Aiba","year":"2008","unstructured":"Aiba, Y., Kameyama, M., Yamazaki, T., Tedder, T.F. & Kurosaki, T. Regulation of B cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase. Blood 111, 1497\u20131503 (2008).","journal-title":"Blood"},{"key":"BFnm4062_CR16","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1084\/jem.20122768","volume":"210","author":"M Tesio","year":"2013","unstructured":"Tesio, M. et al. Pten loss in the bone marrow leads to G-CSF\u2013mediated HSC mobilization. J. Exp. Med. 210, 2337\u20132349 (2013).","journal-title":"J. Exp. Med."},{"key":"BFnm4062_CR17","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1182\/blood-2009-06-228130","volume":"115","author":"C Peng","year":"2010","unstructured":"Peng, C. et al. PTEN is a tumor suppressor in CML stem cells and in BCR-ABL\u2013induced leukemias in mice. Blood 115, 626\u2013635 (2010).","journal-title":"Blood"},{"key":"BFnm4062_CR18","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","volume":"275","author":"J Li","year":"1997","unstructured":"Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 275, 1943\u20131947 (1997).","journal-title":"Science"},{"key":"BFnm4062_CR19","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1084\/jem.20101691","volume":"208","author":"A Gutierrez","year":"2011","unstructured":"Gutierrez, A. et al. Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J. Exp. Med. 208, 1595\u20131603 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnm4062_CR20","doi-asserted-by":"publisher","first-page":"13520","DOI":"10.1073\/pnas.0804295105","volume":"105","author":"G Lenz","year":"2008","unstructured":"Lenz, G. et al. Molecular subtypes of diffuse large B cell lymphoma arise by distinct genetic pathways. Proc. Natl. Acad. Sci. USA 105, 13520\u201313525 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm4062_CR21","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1084\/jem.20091962","volume":"207","author":"AV Miletic","year":"2010","unstructured":"Miletic, A.V. et al. Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases. J. Exp. Med. 207, 2407\u20132420 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnm4062_CR22","doi-asserted-by":"publisher","first-page":"12420","DOI":"10.1073\/pnas.1305656110","volume":"110","author":"M Pfeifer","year":"2013","unstructured":"Pfeifer, M. et al. PTEN loss defines a PI3K-AKT pathway\u2013dependent germinal center subtype of diffuse large B cell lymphoma. Proc. Natl. Acad. Sci. USA 110, 12420\u201312425 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm4062_CR23","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1158\/1535-7163.MCT-06-0334","volume":"5","author":"R Tibes","year":"2006","unstructured":"Tibes, R. et al. Reverse-phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol. Cancer Ther. 5, 2512\u20132521 (2006).","journal-title":"Mol. Cancer Ther."},{"key":"BFnm4062_CR24","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1200\/JCO.2005.01.4944","volume":"23","author":"J Roman-Gomez","year":"2005","unstructured":"Roman-Gomez, J. et al. Lack of CpG island methylator phenotype defines a clinical subtype of T cell acute lymphoblastic leukemia associated with good prognosis. J. Clin. Oncol. 23, 7043\u20137049 (2005).","journal-title":"J. Clin. Oncol."},{"key":"BFnm4062_CR25","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nature03918","volume":"436","author":"Z Chen","year":"2005","unstructured":"Chen, Z. et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725\u2013730 (2005).","journal-title":"Nature"},{"key":"BFnm4062_CR26","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.immuni.2008.10.013","volume":"29","author":"F K\u00f6hler","year":"2008","unstructured":"K\u00f6hler, F. et al. Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells. Immunity 29, 912\u2013921 (2008).","journal-title":"Immunity"},{"key":"BFnm4062_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0092-8674(04)00419-2","volume":"117","author":"H Xie","year":"2004","unstructured":"Xie, H., Ye, M., Feng, R. & Graf, T. Stepwise reprogramming of B cells into macrophages. Cell 117, 663\u2013676 (2004).","journal-title":"Cell"},{"key":"BFnm4062_CR28","doi-asserted-by":"publisher","first-page":"11137","DOI":"10.1073\/pnas.0900465106","volume":"106","author":"DB Shackelford","year":"2009","unstructured":"Shackelford, D.B. et al. mTOR and HIF-1\u03b1\u2013mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome. Proc. Natl. Acad. Sci. USA 106, 11137\u201311142 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm4062_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","volume":"39","author":"K D\u00fcvel","year":"2010","unstructured":"D\u00fcvel, K. et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 39, 171\u2013183 (2010).","journal-title":"Mol. Cell"},{"key":"BFnm4062_CR30","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1021\/cb600352f","volume":"1","author":"E Rosivatz","year":"2006","unstructured":"Rosivatz, E. et al. A small-molecule inhibitor for phosphatase and tensin homolog deleted on chromosome 10 (PTEN). ACS Chem. Biol. 1, 780\u2013790 (2006).","journal-title":"ACS Chem. Biol."},{"key":"BFnm4062_CR31","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1182\/blood-2010-09-309864","volume":"117","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. Pretreatment with phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibitor SF1670 augments the efficacy of granulocyte transfusion in a clinically relevant mouse model. Blood 117, 6702\u20136713 (2011).","journal-title":"Blood"},{"key":"BFnm4062_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nature14231","volume":"521","author":"Z Chen","year":"2015","unstructured":"Chen, Z. et al. Signaling thresholds and negative B cell selection in acute lymphoblastic leukemia. Nature 521, 357\u2013361 (2015).","journal-title":"Nature"},{"key":"BFnm4062_CR33","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ccell.2015.05.008","volume":"28","author":"S Shojaee","year":"2015","unstructured":"Shojaee, S. et al. Erk negative feedback control enables pre B cell transformation and represents a therapeutic target in acute lymphoblastic leukemia. Cancer Cell 28, 114\u2013128 (2015).","journal-title":"Cancer Cell"},{"key":"BFnm4062_CR34","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1172\/JCI33337","volume":"118","author":"MG Kharas","year":"2008","unstructured":"Kharas, M.G. et al. Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K-mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells. J. Clin. Invest. 118, 3038\u20133050 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnm4062_CR35","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1101\/gr.5273806","volume":"16","author":"B Khulan","year":"2006","unstructured":"Khulan, B. et al. Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res. 16, 1046\u20131055 (2006).","journal-title":"Genome Res."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.4062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.4062","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.4062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:56:09Z","timestamp":1684450569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.4062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,14]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["BFnm4062"],"URL":"https:\/\/doi.org\/10.1038\/nm.4062","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,14]]},"assertion":[{"value":"11 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}